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Introduction 3 
Phyllodes tumour is a rare fibroepithelial breast tumour which arises from the periductal 4 
stroma of the breast, it accounts for less than 1% of all primary breast tumours. (1,2) They 5 
can occur at any age but are most frequent in the fourth decade with earlier onset in those of 6 
Asian origin.(3,4) Phyllodes tumours can be divided into benign, borderline and malignant 7 
subtypes, depending on histological parameters such as nature of tumour borders, degree of 8 
stromal cellularity and atypia, mitotic count and stromal overgrowth. (5,6) Fibroadenoma is a 9 
very common fibroepithelial tumour which shares some characteristics with phyllodes 10 
tumour, but has a younger age distribution.(1) Differentiating between phyllodes and 11 
fibroadenoma tumours is difficult as clinical, radiological and histopathologic appearance 12 
may mimic each other with a definitive diagnosis only being made after microscopic analysis 13 
of the entire excised lesion.(1) Despite their similarities, fibroadenomas are benign and are 14 
managed either conservatively or by enucleation without surgical margins while phyllodes 15 
tumours require excision with clear margins to avoid recurrence particularly in the borderline 16 
and malignant subtypes. (7–11) Accurate identification pre-operatively is critical for 17 
appropriate surgical planning to avoid complications from overtreatment or inadequate 18 
excision.(10) 19 
Imaging modalities used in the assessment of breast disease include mammography, 20 
ultrasound and Magnetic Resonance Imaging (MRI). Ultrasound elastography is the most 21 
recent imaging modality employed in differentiating between malignant and benign lesions 22 
by assessing the stiffness within lesions which has proved an accessory tool in assessing 23 
breast masses.(1) Studies evaluating the use of MRI suggests that both phyllodes and 24 
fibroadenoma show similar findings.(12) Immunohistochemical markers have been 25 
suggested to increase accuracy in distinguishing between fibroepithelial tumours but 26 
histology remains the gold standard.(8,13)  27 
Recent guidelines suggest benign phyllodes tumours do not need excision with margins but 28 
borderline and malignant phyllodes require excision with a clear margin to reduce the risk of 29 
local recurrence and potential distant metastases.(14) However, core biopsy cannot reliably 30 
differentiate between fibroadenomas and phyllodes tumour subtypes, which can be 31 
explained pathologically due their heterogeneity.(15)  As such, it can be difficult for the 32 
surgeon to predict whether a margin is required or not from the preoperative information. If a 33 
more accurate prediction of the likely nature of the lesion as fibroadenoma or benign 34 
phyllodes versus borderline or malignant phyllodes were available, this could reduce 35 
unnecessary margin excision and cosmetic compromise, or avoid second operations to 36 
achieve clear margins.  37 
Previous studies have compared the imaging features of fibroadenomas and phyllodes 38 
tumours (1,16,17) but none has compared the imaging features of those lesions requiring 39 
excision with a margin and those which do not.(18) In this study, we aimed to identify 40 
ultrasound and mammographic features associated with borderline and malignant phyllodes 41 
versus benign phyllodes and fibroadenomas to aid surgical planning. 42 
Methodology 43 
A prospective database of consecutive ultrasound visible masses was used to identify 44 
lesions with a core biopsy suggestive of a phyllodes tumour in a single unit between May 45 
2010 and January 2019. Masses with an ultrasound core biopsy result of B3, raising the 46 
possibility of a phyllodes tumour were included. 47 
The breast ultrasound features assessed were: mass shape and size; orientation; margin 48 
definition; presence of macro-lobulations and micro-lobulations; echogenicity; cystic spaces; 49 
echogenic clefts; skin involvement; surrounding oedema; Breast Imaging Reporting And 50 
Data System (BIRADS) score(19); posterior features and vascularity. BIRADS score allows 51 
for unambiguous reporting of breast imaging and is graded from incomplete to proven 52 
malignancy, with scores of 0 to 6 respectively. For this study, only lesions with a BIRADS 53 
score of at least 3 were included. 54 
Mammographic features assessed included presence of a mass; calcification; margin 55 
definition and BIRADS score. Breast density was assessed using the BIRADS 56 
classification(19) and a Visual Analogue Scale (VAS). (20) Breast density or composition, 57 
was assessed in terms of the proportion of fibroglandular tissue with the least dense breast 58 
graded as BIRADS density ‘a’ and the most dense graded as BIRADS density ‘d’. In 59 
addition, a 10cm visual analogue scale presented on paper sheets was used, with the 60 
approximate percentage of dense breast tissue marked with the right side of line marking 61 
100% density and the left marking 0% density. Inter-rater agreement was achieved via 62 
discussion. 63 
Excision surgical pathology was recorded, and lesions were classified, using definitions 64 
described earlier (5,6) as a benign phyllodes/ fibroadenoma or as a borderline/malignant 65 
phyllodes if a margin was required. Ultrasound and mammographic features in these 2 66 
groups were compared. Statistical analysis used Chi-square, Fisher’s exact test and 67 
receiver-operating curve (ROC). 68 
Attention was paid to features previously described to be suggestive of a phyllodes tumour. 69 
Imaging features were carried out by an experienced consultant radiologist who was blinded 70 
to the final pathology outcomes. For our study, benign phyllodes and fibroadenoma were 71 
grouped as not needing a margin whereas borderline and malignant phyllodes were grouped 72 
as needing a margin.(8,14) 73 
Results 74 
31 patients with 31 lesions meeting the inclusion criteria were identified. Of these, 6 lesions 75 
were screen-detected, all of which were benign, and 25 were symptomatic. There were 13 76 
lesions requiring a margin (6 malignant, 7 borderline) and 18 benign lesions not requiring a 77 
margin (13 benign phyllodes, 4 fibroadenoma and 1 other). The average age of study 78 
patients was 53 years old, (range 22- 84 years). 25 patients had mammograms performed, 79 
with the lesion being mammographically occult in 3, leaving 22 to be included in analysis. All 80 
31 patients had a breast ultrasound. 81 
Table 1. Categorical ultrasound features assessed in borderline/malignant phyllodes and 82 
fibroadenoma/benign phyllodes. 83 
Table 2. Categorical mammographic features assessed in borderline/malignant phyllodes 84 
and fibroadenoma/benign phyllodes. 85 
The following ultrasound features were found significantly more frequently in those lesions 86 
that were borderline/malignant phyllodes as shown in table 1;  an irregular margin [8/13 87 
(62%) vs 3/18 (17%) p= 0.01], presence of micro-lobulations [7/13 (54%) vs 3/18 (17%) p = 88 
0.028], mixed echogenicity [9/13 (69%) vs 1/18 (6%) p = 0.0002], echogenic clefts [6/13 89 
(46%) vs 1/18 (6%) p = 0.007), BIRADS score of more than 3 [11/13 (85%) vs 9/18 (50%) 90 
p=0.047], posterior enhancement (9/11 (82%) vs 6/18 (33%) p=0.01]. 91 
Large ultrasound size was significantly associated with borderline and malignant phyllodes 92 
tumours with an area under the curve (AUC) of 0.76, p=0.003 as shown in figure 1.  93 
Stiffness at shock wave elastography (SWE) was also associated with borderline and 94 
malignant phyllodes, AUC 0.71, p=0.026 as shown in figure 2.  95 
On mammography, fibroadenoma and benign phyllodes tumours had well-defined margins 96 
compared to the borderline/ malignant Phyllodes tumours [7/9 (78%) vs 4/13 (31%), p=0.04] 97 
as shown in table 2. No other mammographic features were statistically significant.  98 
Mode of presentation was a significant factor with symptomatic lesions being more likely to 99 
require a margin than screen-detected lesions [13/13 (100%) vs 6/18 (33%) p=0.005], 100 
respectively.  101 
Discussion 102 
In this study, we have identified multiple pre-operative features that are significantly different 103 
between lesions requiring a margin and those that do not. In this study we grouped benign 104 
phyllodes and fibroadenoma as lesions not needing a margin and borderline and malignant 105 
phyllodes as lesions needing a margin. A previous study found that although differentiating 106 
between fibroadenomas and phyllodes tumours is difficult even for pathologists specialised 107 
in breast pathology, there is a inter-rater agreement when fibroadenomas and benign 108 
phyllodes are distinguished from malignant and borderline subtypes. (8) 109 
This study shows that there are a number of pre-operative differentiating features between 110 
fibroadenoma and benign phyllodes versus borderline and malignant phyllodes found on 111 
ultrasound. The features suggesting borderline and malignant phyllodes, and thus the need 112 
for a surgical excision with margin include an irregular shape, micro-lobulations, high 113 
echogenicity, BIRADS score > 3, distal enhancement, large size and stiffness on SWE. In 114 
addition, a mammographic poorly-defined margin and symptomatic presentation suggest the 115 
need for a margin at excision. 116 
We found increasing size to be a significant factor in predicting the need for a surgical 117 
margin. This is in agreement with a previous study which found that mean lesion size 118 
increased when comparing benign, borderline and malignant phyllodes tumours.(18)  119 
However, this study did not include any fibroadenomas. 120 
As the number of differentiating factors shown is high, a multivariate analysis to find those 121 
with independent significance would be helpful. Unfortunately, our dataset is too small for 122 
multivariate analysis to be performed. 123 
The lack of a radiological, well-defined margin in borderline and malignant phyllodes mirrors 124 
the pathological findings of infiltrative margins and stromal overgrowth in such tumours. (21) 125 
The posterior enhancement may reflect the desmoplastic growth of tumour stromal cells in 126 
borderline and malignant lesions as it is known that posterior enhancement is found more 127 
frequently in high grade invasive cancers than low grade. (22) 128 
Micro-lobulations are probably a reflection of an infiltrative margin as they are common 129 
features of an invasive cancer but uncommon in fibroadenomas. When found in 130 
fibroadenomas, they are thought to be due to hyalinisation or infarction leading to fibrous 131 
changes that increase the stromal component.(23) The high ultrasound BIRADS score in the 132 
borderline and malignant phyllodes is likely to reflect both infiltrative margins and the 133 
increased heterogeneity seen in these lesions. 134 
Increased stiffness in invasive breast cancer has been shown to reflect active tumour 135 
stromal interaction.(24) Although tumour stromal interaction in malignant phyllodes is not 136 
well understood, it is possible that increased stiffness at shear wave elastography reflects 137 
activated tumour associated fibroblasts and the production of stiff collagen.(25,26) Stiffness 138 
on shear wave elastography may also reflect the increased cellularity of the stroma in 139 
phyllodes tumour compared to fibroadenoma.(1)  140 
Although the number of screening-detected lesions in the study is small, it is striking that 141 
they were all benign phyllodes or fibroadenomas. The reason for this is not clear but may 142 
reflect their small size and impalpability.  143 
Although peri-lesional oedema was not found to be a significant feature in our study, some 144 
studies(16,27) have found that rapidly growing tumours have surrounding interstitial oedema 145 
due to the compressed lymphatics or mammary ducts best seen on T2-weighted MRI 146 
images. Patients in this study did not routinely undergo MRI and, as such, this could not be 147 
studied in this cohort. 148 
The small sample size from a single centre is the largest limitation in this study. Further 149 
studies should aim to include more cases from multiple centres. A larger sample size would 150 
enable multivariate analysis to identify independent factors. In addition, there were not 151 
enough MRI scans for this modality to be evaluated.  152 
Conclusion 153 
We have identified multiple ultrasound and mammographic features that may be used to 154 
guide surgeons’ decisions regarding the use of a margin when excising lesions suggestive of 155 
a phyllodes tumour. Due to our small sample size, further studies involving larger numbers 156 
are required to validate our results. 157 
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 236 
Figure 1: Receiver Operating Curve showing the association between ultrasound size of the 237 
lesion and borderline and malignant phyllodes tumour subtypes.  238 
 239 
Figure 2: Receiver operating curve (ROC) showing the association between stiffness of the 240 
lesion and borderline and malignant phyllodes tumour subtypes. 241 
 242 
Table 1: Categorical ultrasound features assessed in borderline/malignant phyllodes and 243 
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2 One lesion was unassesable. 































Table 2: Categorical mammographic features assessed in borderline/malignant phyllodes 246 




















































                                                          
4 Two lesions were unassesable. 

































1 3 lesions were mammographically occult. 248 
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